Sorry, you need to enable JavaScript to visit this website.

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis. Open-Label Safety and Efficacy Evaluation of Tafamidis Meglumine in Subjects With Transthyretin  Amyloidosis (ATTR Amyloidosis)

Category & Conditions: Neurological Diseases and Conditions
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
ClinicalTrials.gov Identifier (NCT): NCT00925002
Protocol ID: B3461023
    Share
PrintDownload
Open Plain Language Summary Result: Click here